Model
Edge
Plus Therapeutics, Inc.
0001307632
Filing Type
4
Filing Date
9/15/2024
Updated
9/16/24, 5:00 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership